Delivering Therapies To Patients At Scale And At Speed

Resilience Was Born To Address Two Defining Challenges

1. Manufacturing supply chains are needed that can withstand disruptive shocks and safeguard health security.
2. Biopharmaceutical manufacturing has not kept pace with scientific advancement, preventing new discoveries from reaching patients at speed or scale.

Watch this conversation With Resilience CEO And Director, Rahul Singhvi.